| Systematic (IUPAC) name | |
|---|---|
| 5-amino-4-oxo-pentanoic acid | |
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | ? |
| Identifiers | |
| CAS number | 106-60-5 |
| ATC code | L01XD04 |
| PubChem | CID 137 |
| DrugBank | APRD00793 |
| ChemSpider | 134 |
| UNII | 88755TAZ87 |
| KEGG | D07567 |
| ChEBI | CHEBI:356416 |
| ChEMBL | CHEMBL601 |
| Chemical data | |
| Formula | C5H9NO3 |
| Mol. mass | 131.13 g/mol |
| SMILES | eMolecules & PubChem |
|
|
| (what is this?) (verify) |
|
δ-Aminolevulinic acid (dALA or δ-ALA or 5ala or 5-aminolevulinic acid ) is the first compound in the porphyrin synthesis pathway, the pathway that leads to heme in mammals and chlorophyll in plants.
In plants, production of δ-ALA is the step on which the speed of synthesis of chlorophyll is regulated. Plants that are fed by external δ-ALA accumulate toxic amounts of chlorophyll precursor, protochlorophyllide, indicating that the synthesis of this intermediate is not suppressed anywhere downwards in the chain of reaction. Protochlorophyllide is a strong photosensitizer in plants.
Contents |
In non-photosynthetic eukaryotes such as animals, insects, fungi, and protozoa, as well as the α-proteobacteria group of bacteria, it is produced by the enzyme ALA synthase, from glycine and succinyl CoA. This reaction is known as the Shemin pathway.
In plants, algae, bacteria (except for the α-proteobacteria group) and archaea, it is produced from glutamic acid via glutamyl-tRNA and glutamate-1-semialdehyde. The enzymes involved in this pathway are glutamyl-tRNA synthetase, glutamyl-tRNA reductase, and glutamate-1-semialdehyde aminotransferase. This pathway is known as the C5 or Beale pathway.[1][2]
It elicits synthesis and accumulation of fluorescent porphyrins (protoporphyrin IX) in epithelia and neoplastic tissues, among them malignant gliomas. It is used to visualise tumorous tissue in neurosurgical procedures. Studies have shown that the intraoperative use of this guiding method may reduce the tumour residual volume and prolong progression-free survival in patients suffering from this disease.[3]
Aminolevulinic acid is also a photosensitizer for photodynamic therapy.
Photodynamic detection (PDT) is the use of photosensitive drugs with a light source of the right wavelength for the detection of cancer, using fluorescence of the drug. PDT treatment possibilities include those for cancer of the prostate, breast, giant BCC (skin), cervix, recurrent bladder, vulvar, brain (human glioblastoma cells), HPV, lung, stomach, head and neck, penis, and colon, as well as those for leukemia, Barrett's oesophagus, squamous cell carcinoma (SCC), Bowen's disease, and other types of cancer.
|
|||||||||||||||||||||||